within Pharmacolibrary.Drugs.R_RespiratorySystem.R03B_OtherDrugsForObstructiveAirwayDiseasesInhalants.R03BA01_Beclometasone;

model Beclometasone
  extends Pharmacolibrary.Drugs.ATC.R.R03BA01;

  annotation (Documentation(
info       = "<html><body><table><tr><td>name:</td><td>Beclometasone</td></tr><tr><td>ATC code:</td><td>R03BA01</td></tr><td>route:</td><td>inhalation</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Beclometasone is a synthetic corticosteroid with potent anti-inflammatory properties, commonly used as an inhaled treatment for asthma and allergic rhinitis. It acts by reducing airway inflammation and bronchial hyperresponsiveness. Beclometasone is approved and widely used in current clinical practice.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic data reported for healthy adult volunteers (both sexes) after inhalation administration.</p><h4>References</h4><ol><li><p>Kuna, P, et al., &amp; Ciurlia, G (2022). Pharmacokinetics of extrafine beclometasone dipropionate/formoterol fumarate/glycopyrronium bromide in adolescent and adult patients with asthma. <i>Pharmacology research &amp; perspectives</i> 10(4) e980–None. DOI:<a href=\"https://doi.org/10.1002/prp2.980\">10.1002/prp2.980</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/35733414/\">https://pubmed.ncbi.nlm.nih.gov/35733414</a></p></li><li><p>Mansfield, LE (2015). Beclomethasone HFA for the treatment of allergic rhinitis. <i>Expert opinion on pharmacotherapy</i> 16(18) 2849–2857. DOI:<a href=\"https://doi.org/10.1517/14656566.2015.1115014\">10.1517/14656566.2015.1115014</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/26653155/\">https://pubmed.ncbi.nlm.nih.gov/26653155</a></p></li><li><p>Luo, Z, et al., &amp; Mariotti, F (2022). Pharmacokinetic profile of beclometasone dipropionate/formoterol fumarate administered through a novel dry-powder inhaler in Chinese healthy volunteers. <i>Pulmonary pharmacology &amp; therapeutics</i> 73-74 102129–None. DOI:<a href=\"https://doi.org/10.1016/j.pupt.2022.102129\">10.1016/j.pupt.2022.102129</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/35525480/\">https://pubmed.ncbi.nlm.nih.gov/35525480</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial generated model</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Beclometasone;
